We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$394B
AUM Growth
+$44.6B
Cap. Flow
+$6.63B
Cap. Flow %
1.68%
Top 10 Hldgs %
19.2%
Holding
3,619
New
44
Increased
2,356
Reduced
681
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Financials 12.41%
3 Healthcare 11.8%
4 Consumer Discretionary 10.03%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSVN icon
3226
Bank7 Corp
BSVN
$486M
$290K ﹤0.01%
10,592
SLNO
3227
DELISTED
Soleno Therapeutics
SLNO
$290K ﹤0.01%
+7,195
New +$205K
TUSK icon
3228
Mammoth Energy Services
TUSK
$158M
$285K ﹤0.01%
63,981
CUE icon
3229
Cue Biopharma
CUE
$119M
$279K ﹤0.01%
3,523
+320
+10% +$22.9K
MPX
3230
DELISTED
Marine Products Corp
MPX
$278K ﹤0.01%
24,393
PPTA
3231
Perpetua Resources
PPTA
$3.18B
$274K ﹤0.01%
86,353
PLX icon
3232
Protalix BioTherapeutics
PLX
$196M
$273K ﹤0.01%
153,561
XFOR icon
3233
X4 Pharmaceuticals
XFOR
$424M
$272K ﹤0.01%
10,795
SNN icon
3234
Smith & Nephew
SNN
$12.6B
$271K ﹤0.01%
+9,916
New +$246K
CTXR icon
3235
Citius Pharmaceuticals
CTXR
$19.8M
$270K ﹤0.01%
14,280
VCSA
3236
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$269K ﹤0.01%
32,747
+10,394
+46% +$84.2K
KPTI icon
3237
Karyopharm Therapeutics
KPTI
$47.6M
$268K ﹤0.01%
20,661
+3,400
+20% +$45.8K
ERIC icon
3238
Ericsson
ERIC
$33B
$263K ﹤0.01%
41,706
-46,373
-53% -$235K
SKYX icon
3239
SKYX Platforms
SKYX
$165M
$262K ﹤0.01%
163,846
ASRT
3240
DELISTED
Assertio
ASRT
$262K ﹤0.01%
16,321
-13,728
-46% -$339K
OPTN
3241
DELISTED
OptiNose
OPTN
$262K ﹤0.01%
13,521
CCRD
3242
DELISTED
CoreCard
CCRD
$260K ﹤0.01%
18,769
LBPH
3243
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$259K ﹤0.01%
42,933
VTWO icon
3244
Vanguard Russell 2000 ETF
VTWO
$17.3B
$255K ﹤0.01%
+3,150
New +$228K
KWY
3245
Kingsway Corp
KWY
$282M
$255K ﹤0.01%
30,322
KVHI icon
3246
KVH Industries
KVHI
$141M
$254K ﹤0.01%
48,261
EEX
3247
DELISTED
Emerald Holding
EEX
$254K ﹤0.01%
42,398
VONE icon
3248
Vanguard Russell 1000 ETF
VONE
$8.65B
$251K ﹤0.01%
+1,156
New +$234K
OPRA
3249
Opera Ltd
OPRA
$1.79B
$249K ﹤0.01%
18,791
+3,139
+20% +$37.1K
VLD
3250
DELISTED
Velo3D, Inc.
VLD
$246K ﹤0.01%
17,672
-417
-2% -$16K

Similar funds

Charles Schwab's Q4 2023 Portfolio in Review

As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
  • Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
  • Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
  • Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
  • Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
  • Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
  • Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.